Member Info for Toyin

6/12/22 4066
28/12/22 4245
21/1/23 4474
1/2/23 4562

bel, I believe in free speech so no need to put you on ignore, but I will call you out if I think you are wrong in what you say, I hope you and other investors call me out if I am wrong. I have no idea what you mean by "our actions" so will leave that be. As for rose tinted specs, I have said many times that the £1.2m was a disaster, Axis sales were/are disappointing and that this year is pivotal for SA and the company. Am I happy with where we are, no absolutely not, but I choose to look forward not backwards, if that's rose tinted no problem. If you want to talk foolish, anybody who invests on what I say is a complete moron, each investor should follow their own path. What I dont understand is all this bleating and whinging from some investors, why bother investing here if you're that disgruntled, it doesn't make any sense but each to there own.

Regarding lack of proper company information, if he hasn't got any what do you want him to do, make some up? As for costing shareholders serious money, I cant comment as I dont know how much any other shareholders have invested.

All the best.

bel, if you're going to threaten it you might as well do it.

bel, Farris is correct about what exactly, and I am wrong again about what exactly? Be specific, like I was with your 15 month rubbish!

Re the NPF, yes something did happen, they didn't take the distribution deal so the door was closed, what's difficult to understand about that?

Re SA's renumeration, at the last AGM 92% of shareholders were obviously quite happy with SA's progress and voted accordingly. If you're not happy email the company and tell them so. As for the rest of your ramblings, if you are that disgruntled what the hell are you doing investing in this company?

Like I have said multiple times before, this year is pivotal for SA and the Co and if it doesn't work out I will be on my way, what I wont do is come on here complaining about the ceo's renumeration, its poor form!

Farris, re the UK, I remember him saying he was talking to them but please point me to where he says "the psoriasis association were all over our product." Re America, access to that association was linked to one of the distribution deals which the board decided not to take.

No problem Aquae, I worked it out. Yes the 600 litre vessel was enough to satisfy the 12 vip’s, but to what point, I would suggest not long term or there would be no need for a 20,000 litre vessel. It certainly wouldn’t be enough to satisfy 12,000 customers, so you have to run the 20,000 vessel before you decide your strategy. They didn’t know that until after Sept 22, not as bel suggests, 15 months ago. bel is wrong, end of.

I’m going to sleep, nighty night.

Farris, how has he deceived?

Aquae, if you find enhancements/additional activities when you scale up to 600 litres you have to prove that’s the product the customer will get at 20,000 litres. They obviously didn’t expect to find additional activity at 600 litres so when they did, the situation changed. The point being the 20,000 litre vessel wasn’t ready until earliest sept 2022 so there is no way Croda could 100% guarantee the enhancement/additional activities were present at 20,000 litres until after that date. So no, bel is wrong and talking out of his **** because 15 months ago we didn’t know if the enhancements where present at the (commercial) 20,000 litres. The only caveat to that would be that if the enhancements weren’t present at 20,000 litres they could go back and run multiple 600 litre vessels, but they wouldn’t have the data to use that option until after Sept 2022.

Farris, let’s take this one step at a time, which part would you like me to explain first.

Aquae, not really, Elric was agreeing with me, so explain what you mean.

Farris, it sounds like your head has fallen off, when you find it please join in.

Aquae, it didn’t impact the scale up, but you still have to prove the additional enhancements are there at 20,000 litres. Let me explain in layman’s terms. Sbtx give Sederma a lysate, Sederma then scale it up to 600 litres and find enhancements and additional activities different from the original lysate that Sbtx supplied them. Now at Nov 21 they had not run it at 20,000 litres because the vessel didn’t exist, so until they do that they don’t know if these additional enhancements/activities would still be present because they can leave as fast as they arrive. So in summary, until they did a run at 20,000 litres and analysed the lysate they wouldn’t know if the enhancements/activities where still present, which at best is 3 months ago. Is that clear?

Bel, they had to confirm that the enhancements were visible at scale up in the 20,000 litre vessel which was not 15 months ago. On my calculations the 20,000 litre vessel was running from no earlier than Sept 22 and then they would have to analyse the lysate after that. So in reality it’s probably no more than 3 months. Please feel free to correct me.

Yes Farris, maybe the technology isn’t all it’s cracked up to be, that’s why it helps with psoriasis, eczema, acne, psoriatic arthritis, etc, etc, also Croda a ftse 100 co have spent three years and €5m on a dedicated production line, they have also found enhancements and additional activities that have excited them, plus the lysate is not the be-all and end-all; this is just the beginning of a multi-channel/product journey that has only just started, plus we have multinationals that are interested in the whole axis pillar. It’s called science, it takes time.

Like WB said “If you aren't willing to own a stock for ten years, don't even think about owning it for ten minutes.”

bel, As you point out the company stated in the rns that Sederma is awaiting the outcome of its marketing to its clients expected Q4 2022. But as I previously stated, if Sederma/Croda dont want to play ball there is nothing SA can do, if there was anything negative or a slip that was material, it would have to be rns'd immediately. What we do know is they found additional enhancements and activity which has obviously thrown them a curve ball.

They didn't need any feedback quotes to get the raise away. My guess is it was very easy for them to raise the money as the discount was negligible, look at ygen, same month 80% discount to raise money, that surely tells you something.

What plates are falling? As far as I can see, only one has which was the £1.2m, but when you look into why I for one am glad, and that one plate encapsulates your NPF flop, sales, etc, etc as the distribution deals are were the sales were coming from. I agree things need to start moving and I believe they will as I wouldn't still be invested if I thought otherwise.

One last thing, can we keep SA's salary out of discussions, it really is in bad taste. Remember, he could have took the £1.2m deals, earned a massive bonus and everyone would have been calling him a hero. He didn't because it wasn't in the best long term interest of the company.

If Croda haven’t given SA an update there isn’t a lot he can do about it. If he had been informed of anything material either way he would release it. He has said Croda are playing things very close to their chest, I would suggest that includes SA. So I wouldn’t be holding your breath.

Bel, they have already done at least one run on the 20,000 litre vessel. There is no further scale up.

mol, in that discussion I never tried to link it to the potential acquisition and I never said it wasn't standard. I was simply pointing out that it was a "special" resolution and it was in relation to an "acquisition" because that is what the rns states. What you said is 100% wrong and you were and still are talking out your ****. Go back and read the thread as my post has been reinstated. (rightly so and it was reported by me) who says free speech is dead! lol.

I would now like to deal with the "transformational" issue. A quote from SA in Elrics Q&A from December, focus on the last word. (as I have said before, well worth rereading)

"Those multinationals are keen on that in our conversations, which began some time ago. Since then, this accretive opportunity presented itself - very timely indeed, and so will hang on, we could actually change the topical portfolio, back our science in the business to triple next generation and also in combining with the food supplement to have a system that we know is attractive to these multinationals. That’s part of the strategic mindset that’s partly strategic planning, but it was always the mission of the Company from the IPO built on probiotic and topical treatments. So this acquisition fits superbly – It is a transformation!"

Regarding slipped targets, I agree to a point, but we need to be specific and discuss each one in isolation or it gets messy. For e.g, I believe (as I have said before) Croda has slipped because of the enhancements and the additional activity. For me this isn't a concern, in fact its a positive. Others may see it differently.

Regarding hitting targets, you have to be specific, list them and ask the company, or post them here and I will ask for you.

Your last paragraph is just assumption and personal attacks. How do you know we will write off £250k of stock? I'm not saying we wont, I just don't have the facts, do you? Why is his salary out of proportion, the board were happy to pay him that when he joined, he also took a massive pay cut when he joined the company. Regarding his past mate, if he is the right man for the job, whats the problem? He has been with us for two minutes, give him a chance. I would also like to make the point that if SA had took the £1.2m distribution deals he would have been a lot better off financially, he didn't take it, why?

I believe this year is extremely important for SA and the company, having said that, we are only just in February. Your constant bleating is pathetic, if you don't like or rate the CEO or his progress you have two options, 1, contact the company air your concerns and if you are happy with the response hold, 2, if not, sell. Coming on here moaning all the time doesn't solve anything or help anyone.

"Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble." Warren Buffett.

mol, you said, and I quote, "all resolutions are ordinary resolutions and have absolutely nowt to do with any process involving any potential acquisition"

That statement is factually incorrect, it is also a "special resolution" yet you say it's "ordinary"

So just for accuracy, you are 100% wrong and talking out your ****!

mol, just for accuracy, I would like you to focus your attention on resolution 6 in today's rns.